Patent Assignment
Reel/Frame 050467/0081
Rescission
Recorded: 2019-09-12
Pages: 7
Assignor
HAR-NOY, MICHAEL
Executed: 2019-09-12
Assignee
HAR-NOY, MICHAEL
16 WASHINGTON ST,B3-61, JERUSALEM, 9695101, ISRAEL
Covered Properties
(54)
Vaccine compositions and methods
Th1 vaccination priming for active immunotherapy
Kit for increasing Th1 cells
Application:
15/630,581 →
Publication:
US 2017/0290857
Compositions for Liquidation of Tumors
Application:
15/084,206 →
Publication:
US 2016/0206718
Methods and compositions for inhibition of Treg cells
Application:
15/245,845 →
Publication:
US 2016/0361404
Methods for handling biological drugs containing living cells
Allogeneic T-Cell Compositions for Induction of Il-12
Vaccine Comprising Allogeneic T-Cells
Method of Vaccinating Using Allogeneic Cells
Automated Device for Biologic Drug Distribution
Automated Device for Biologic Drug Distribution
Ablative Immunotherapy
Application:
15/077,525 →
Publication:
US 2016/0243231
Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
Method for allogeneic cell therapy
Method for Allogeneic Cell Therapy
Compositions for Allogeneic Cell Therapy
Methods for Preparing T-Cells for Cell Therapy
T-Cell Therapy Formulation
Allogeneic Cellular Immunotherapy for Opportunistic Infection
Ablative Immunotherapy
Biodegradable T-Cell Activation Device
Method for Stimulating a Host Immune System by Administering an Allogeneic Cell Material
Vaccine compositions and methods
Application:
12/434,168 →
Publication:
US 2012/0128656
Method of Preparing a Treatment Effective Amount of Allogeneic T-Cells
Th1 vaccination priming for active immunotherapy
T-Cell Activation Device
Device for Enhancing Immunostimulatory Capabilities of T-Cells
Method for Allogeneic Cell Therapy
Methods and compositions for liquidation of tumors
Application:
12/967,910 →
Publication:
US 2011/0142887
T-Cell Compositions That Elicit Type I Cytokine Response
Methods for Preparing T-Cells for Cell Therapy
Methods and compositions for inhibition of Treg cells
Application:
13/084,900 →
Publication:
US 2011/0250173
Cells expressing TH1 characteristics and cytolytic properties
Application:
13/214,534 →
Publication:
US 2012/0045423
Composition of activated CD4 cells
Method to Formulate T-Cells
Methods for handling biological drugs containing living cells
Induction of IL-12 using immunotherapy
Device for Enhancing Immunostimulatory Capabilities of T-Cells
Method for Stimulating a Host Immune System
Method for Stimulating a Therapeutic Immune Effect in a Patient
Ablative Immunotherapy
Methods to Cause Differentiation of T-Cells for Use in Cell Therapy
Automated device for a biologic drug distribution
Application:
13/659,290 →
Publication:
US 2013/0066465
Ablative immunotherapy
Allogeneic Cell Compositions with Cross-Linked CD3/CD28
Cells expressing Th1 characteristics and cytolytic properties
Cells expressing Th1 characteristics and cytolytic properties
Application:
13/800,066 →
Publication:
US 2013/0196428
Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
Method for Allogeneic Cell Therapy
Method to formulate T-cells
Method for stimulating a host immune system
Methods and compositions for liquidation of tumors
Application:
14/193,832 →
Publication:
US 2014/0178334
Device for enhancing immunostimulatory capabilities of T-cells
Allogeneic cellular immunotherapy for opportunistic infection
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2005
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 015619/0485 →
Assignment of Assignor's Interest
May 17, 2005
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 016022/0396 →
Assignment of Assignor's Interest
May 17, 2005
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 016022/0351 →
Assignment of Assignor's Interest
Jan 20, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 037565/0223 →
Assignment of Assignor's Interest
Feb 18, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 037768/0662 →
Assignment of Assignor's Interest
Mar 8, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 037924/0762 →
Assignment of Assignor's Interest
Mar 23, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 038082/0751 →
Assignment of Assignor's Interest
Mar 23, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 038082/0666 →
Assignment of Assignor's Interest
May 25, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 038720/0246 →
Assignment of Assignor's Interest
Dec 19, 2016
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 040672/0166 →
Assignment of Assignor's Interest
Jul 7, 2017
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 042931/0805 →
Assignment of Assignor's Interest
Jul 7, 2017
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 042931/0646 →
Assignment of Assignor's Interest
Sep 25, 2017
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 043683/0614 →
Assignment of Assignor's Interest
May 22, 2018
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 045875/0672 →
Assignment of Assignor's Interest
Jan 15, 2019
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES, LTD.
Reel/Frame 048014/0630 →
Assignment of Assignor's Interest
Jun 20, 2019
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 049535/0813 →
Assignment of Assignor's Interest
Sep 25, 2019
From: IMMUNOVATIVE THERAPIES, LTD.
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050489/0245 →
Corrective Assignment to Correct the Assignor's Name from Immunovative Therapies, Ltd. to Michael Har-Noy on the Original Cover Sheet Previously Recorded on Reel 050489 Frame 0245. Assignor(S) Hereby Confirms the Assignment.
Oct 2, 2019
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050610/0633 →
Corrective Assignment to Correct the Correct the Address Os the Assignee Previously Recorded at Reel: 050489 Frame: 0245. Assignor(S) Hereby Confirms the Assignment.
Jan 28, 2020
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 052915/0513 →